Tom McLean is a medicinal chemist by training, and the sole in-house attorney for Nimbus Therapeutics and its portfolio companies. He is responsible for devising and implementing the firm’s IP strategy, and overseeing IP diligence, and the IP aspects of partnering transactions. Nimbus applies deep computational chemistry expertise throughout the drug discovery and development process to create novel small molecules for substantial and underserved human diseases in metabolism, oncology and immunology.